- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07655050
Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRS
The Combined Effect of Antibiotic Irrigation and Aspiration Ureteral Access Sheath on Infectious Complications in Retrograde Intrarenal Surgery: A Prospective Randomized Factorial Study
Studieoversikt
Status
Detaljert beskrivelse
Subject:
The present study aims to investigate the effects of gentamicin-containing irrigation and the use of a suction ureteral access sheath during retrograde intrarenal surgery (RIRS) on postoperative infectious complications.
Objective:
The aim of this study is to evaluate the independent and combined effects of gentamicin irrigation and a suction ureteral access sheath on postoperative infectious complications following RIRS.
Retrograde intrarenal surgery (RIRS) is a commonly used minimally invasive treatment modality for renal stones, particularly for stones up to 20 mm. Although RIRS is generally considered safe and effective, postoperative infectious complications remain an important clinical concern. Fever, urinary tract infection, systemic inflammatory response syndrome (SIRS), and sepsis may occur even in patients with negative preoperative urine cultures and appropriate perioperative antibiotic prophylaxis.
A potential mechanism for infectious complications after RIRS is increased intrarenal pressure during endoscopic lithotripsy. Elevated intrarenal pressure may promote pyelovenous and pyelolymphatic backflow, allowing bacteria, endotoxins, and inflammatory mediators from the collecting system or stone surface to enter the systemic circulation. Therefore, strategies that reduce bacterial contamination within the renal collecting system and improve intrarenal drainage may help decrease postoperative infectious morbidity.
This study is designed to evaluate two intraoperative strategies intended to reduce infectious complications during RIRS. The first strategy is local antibiotic irrigation using gentamicin-containing saline solution. Gentamicin will be added to the irrigation fluid as a local intraoperative measure rather than as a systemic treatment. This approach is intended to reduce bacterial contamination within the collecting system during lithotripsy. All patients will also receive standard systemic antibiotic prophylaxis according to routine clinical practice.
The second strategy is the use of a suction-enabled ureteral access sheath. This device is intended to improve fluid evacuation, reduce intrarenal pressure, and facilitate the removal of stone dust, debris, and potentially contaminated fluid during the procedure. By improving drainage from the collecting system, suction-assisted RIRS may theoretically reduce pyelovenous backflow and the risk of postoperative systemic inflammatory or infectious events.
The study uses a 2×2 factorial design, which allows simultaneous evaluation of the independent effects of gentamicin irrigation and suction-enabled ureteral access sheath use, as well as their combined effect. This design is useful because both interventions target different mechanisms that may contribute to infectious complications: local bacterial contamination and elevated intrarenal pressure. The factorial structure will also allow assessment of whether the combination of these two approaches provides an additive or synergistic benefit compared with either intervention alone.
All procedures will be performed under general anesthesia in the lithotomy position using standard endourological techniques. Irrigation will be performed with normal saline under low-pressure conditions. In the gentamicin irrigation groups, 80 mg gentamicin will be added to each 3 L bag of normal saline. In the suction groups, a suction-enabled ureteral access sheath will be used during flexible ureteroscopy. Stone fragmentation will be performed with a holmium:YAG laser using a dusting technique, and a double-J ureteral stent will be placed at the end of the procedure according to the study protocol.
This trial may provide clinically relevant evidence regarding infection-prevention strategies in RIRS. If gentamicin irrigation, suction-assisted access sheath use, or their combination is shown to reduce postoperative infectious complications without compromising surgical success, these approaches may contribute to safer perioperative management in endourological stone surgery.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: AHMET TAŞCI
- Telefonnummer: +905531596690
- E-post: ahmettasci400@gmail.com
Studer Kontakt Backup
- Navn: MUSTAFA SERDAR ÇAĞLAYAN
- Telefonnummer: +90 507 431 1951
- E-post: serdar.09.09@hotmail.com
Studiesteder
-
-
Çorum
-
Çorum, Çorum, Tyrkia (Türkiye), 19040
- Rekruttering
- Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, Türkiye
-
Underetterforsker:
- AHMET TAŞCI
-
Ta kontakt med:
- MUSA EKİCİ
- Telefonnummer: +90 505 751 63 41
- E-post: musaekici@hitit.edu.tr
-
Hovedetterforsker:
- MUSTAFA SERDAR ÇAĞLAYAN
-
Çorum, Çorum, Tyrkia (Türkiye), 19040
- Har ikke rekruttert ennå
- Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, Türkiye
-
Ta kontakt med:
- MUSA EKİCİ
- Telefonnummer: +90364 222 11 02
- E-post: tipfak@hitit.edu.tr
-
Underetterforsker:
- AHMET TAŞCI
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Patients scheduled for retrograde intrarenal surgery (RIRS) due to kidney stones
- Male and female patients aged 18 years or older
- Patients who voluntarily sign the informed consent form
- Patients with sterile urine culture or whose preoperative infection has been treated and urine culture has become sterile
Exclusion Criteria:
- Patients with active urinary tract infection before surgery
- Patients with chronic kidney disease
- Pregnant patients
- Patients with allergy to aminoglycoside-group drugs used in the study protocol, specifically gentamicin
- Cases in which the ureter cannot be accessed and the procedure is postponed by placing a double-J stent instead of performing dilation
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Faktoriell oppgave
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Standard RIRS
Participants in this arm will undergo standard retrograde intrarenal surgery using standard saline irrigation and a standard ureteral access sheath.
This arm will serve as the control group for comparison with gentamicin irrigation, suction-enabled ureteral access sheath use, and the combined intervention.
|
Standard retrograde intrarenal surgery will be performed under general anesthesia in the lithotomy position.
A guidewire will be advanced to the renal pelvis under fluoroscopic guidance, and a ureteral access sheath will be placed when appropriate.
Flexible ureteroscopy will be performed, and stones will be fragmented using a holmium laser with the dusting technique.
Standard saline irrigation will be used during the procedure.
Andre navn:
|
|
Eksperimentell: Standard RIRS With Gentamicin Irrigation
Arm Description: Participants in this arm will undergo standard retrograde intrarenal surgery using gentamicin-containing irrigation fluid. Gentamicin will be added to normal saline irrigation solution during the procedure. A standard ureteral access sheath will be used without suction assistance. |
Standard retrograde intrarenal surgery will be performed under general anesthesia in the lithotomy position.
A guidewire will be advanced to the renal pelvis under fluoroscopic guidance, and a ureteral access sheath will be placed when appropriate.
Flexible ureteroscopy will be performed, and stones will be fragmented using a holmium laser with the dusting technique.
Standard saline irrigation will be used during the procedure.
Andre navn:
Gentamicin-containing irrigation fluid will be used during retrograde intrarenal surgery.
In the gentamicin irrigation groups, 80 mg gentamicin will be added to each 3 L bag of normal saline irrigation solution.
This intervention will be used as a local intraoperative irrigation strategy to reduce bacterial contamination within the renal collecting system and is not intended as systemic antibiotic treatment.
Andre navn:
|
|
Eksperimentell: Suction RIRS
Participants in this arm will undergo retrograde intrarenal surgery using a suction-enabled ureteral access sheath.
The suction-enabled sheath will be used to improve fluid evacuation and reduce intrarenal pressure during the procedure.
Standard saline irrigation will be used without gentamicin.
|
A suction-enabled ureteral access sheath will be used during retrograde intrarenal surgery in the suction groups.
The device is intended to improve fluid evacuation from the renal collecting system, reduce intrarenal pressure, and facilitate removal of irrigation fluid, stone dust, and debris during flexible ureteroscopy.
Andre navn:
|
|
Eksperimentell: Suction RIRS With Gentamicin Irrigation
Participants in this arm will undergo retrograde intrarenal surgery using both gentamicin-containing irrigation fluid and a suction-enabled ureteral access sheath.
Gentamicin will be added to normal saline irrigation solution, and the suction-enabled sheath will be used to improve fluid evacuation and reduce intrarenal pressure during the procedure.
|
Gentamicin-containing irrigation fluid will be used during retrograde intrarenal surgery.
In the gentamicin irrigation groups, 80 mg gentamicin will be added to each 3 L bag of normal saline irrigation solution.
This intervention will be used as a local intraoperative irrigation strategy to reduce bacterial contamination within the renal collecting system and is not intended as systemic antibiotic treatment.
Andre navn:
A suction-enabled ureteral access sheath will be used during retrograde intrarenal surgery in the suction groups.
The device is intended to improve fluid evacuation from the renal collecting system, reduce intrarenal pressure, and facilitate removal of irrigation fluid, stone dust, and debris during flexible ureteroscopy.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Fever
Tidsramme: Within 48 hours after surgery
|
Postoperative fever will be defined as a body temperature greater than 38°C occurring within the first 48 hours after retrograde intrarenal surgery.
|
Within 48 hours after surgery
|
|
Systemic Inflammatory Response Syndrome
Tidsramme: Within 48 hours after surgery
|
Systemic inflammatory response syndrome will be defined as the presence of at least two of the following criteria: body temperature greater than 38°C or less than 36°C, heart rate greater than 90 beats/min, respiratory rate greater than 20 breaths/min, or white blood cell count greater than 12,000/mm³ or less than 4,000/mm³.
|
Within 48 hours after surgery
|
|
Sepsis
Tidsramme: Within 48 hours after surgery
|
Sepsis will be defined as systemic inflammatory response syndrome in the presence of confirmed or suspected infection after retrograde intrarenal surgery.
|
Within 48 hours after surgery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Stone-Free Rate
Tidsramme: 4 weeks after surgery
|
Stone-free status will be evaluated using non-contrast computed tomography.
Residual fragments of 4 mm or less will be considered clinically insignificant.
|
4 weeks after surgery
|
|
Change in White Blood Cell Count
Tidsramme: Baseline and within 48 hours after surgery
|
White blood cell count will be assessed before and after surgery to evaluate postoperative inflammatory response.
|
Baseline and within 48 hours after surgery
|
|
Change in Serum Creatinine
Tidsramme: Baseline and within 48 hours after surgery
|
Serum creatinine levels will be assessed before and after surgery to evaluate renal function changes.
|
Baseline and within 48 hours after surgery
|
|
Urine Culture Positivity
Tidsramme: Within 48 hours after surgery
|
Postoperative urine culture results will be evaluated to identify urinary tract infection and causative microorganisms.
|
Within 48 hours after surgery
|
|
Blood Culture Positivity
Tidsramme: Within 48 hours after surgery
|
Postoperative blood culture results will be evaluated in patients with suspected systemic infection to identify bloodstream infection and causative microorganisms.
|
Within 48 hours after surgery
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Zhong W, Leto G, Wang L, Zeng G. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors. J Endourol. 2015 Jan;29(1):25-8. doi: 10.1089/end.2014.0409.
- Rai A, Aro T, Lynch E, Tabib C, Mikhail D, Wang D, Abraham A, Hoenig D, Smith A, Okeke Z. Novel Irrigation Protocol for Renal Pelvis Sterilization During Percutaneous Nephrolithotomy: A Pilot Study. J Endourol. 2021 Sep;35(9):1320-1325. doi: 10.1089/end.2020.0695. Epub 2021 May 10.
- Corrales M, Sierra A, Doizi S, Traxer O. Risk of Sepsis in Retrograde Intrarenal Surgery: A Systematic Review of the Literature. Eur Urol Open Sci. 2022 Aug 30;44:84-91. doi: 10.1016/j.euros.2022.08.008. eCollection 2022 Oct.
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Urogenitale sykdommer
- Mannlige urogenitale sykdommer
- Calculi
- Patologiske tilstander, anatomiske
- Nyresykdommer
- Urologiske sykdommer
- Kvinnelige urogenitale sykdommer
- Kvinnelige urogenitale sykdommer og graviditetskomplikasjoner
- Urinkalkuli
- Infeksjoner
- Nefrolitiasis
- Patologiske tilstander, tegn og symptomer
- Nyreberegning
- Urinveisinfeksjon
- Toxemia
- Urolithiasis
Andre studie-ID-numre
- ETIK-2026-22
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .